Why is Venmax Drugs falling/rising?

As of 15-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 23.08, reflecting a rise of 1.09 or 4.96%. The stock has shown strong performance recently, gaining 15.63% over the last three days and outperforming its sector by 4.88% today. Despite this positive momentum, the stock has seen a decline of 11.40% over the past month. Additionally, the stock's delivery volume has decreased by 34.6% compared to the 5-day average, indicating a potential drop in investor participation. The stock is currently trading above its 5-day moving averages but below its longer-term moving averages, suggesting mixed signals regarding its trend.
Broader market context indicates that while Venmax has outperformed the Sensex by a significant margin of 21.41% over the past week, the benchmark index has only increased by 1.02% during the same period. Year-to-date, Venmax has also outperformed the Sensex, with a return of 27.94% compared to the index's 5.72%. This strong short-term performance relative to the benchmark highlights the stock's resilience, even as it faces challenges in the longer term. Overall, the recent price increase can be attributed to short-term gains and sector outperformance, despite the decline in investor participation and mixed moving average signals.